Skip to main content
Equibles

Walleye Capital LLC

Position in MGNX — Macrogenics Inc

CIK 1758720 NEW YORK, NY
Back to MGNX Full portfolio

Position in MGNX

as of Jun 30, 2026 · filed Aug 3, 2026
Position Value
$1,885,653
+$916,738 QoQ
Shares Held
408,150
+21.7% QoQ
Ownership
0.641%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#24
of 122 holders
Holding Since
Mar 2022
13 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in MGNX Over Time

Shares Held

Position Value (USD)

Derivatives in MGNX

reported options exposure · as of Jun 30, 2026
CallValue
$11,088
CallShares
2,400
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Walleye Capital LLC holds $328,656,270 across 126 Biotechnology names. MGNX ranks #44 (0.6% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 ASND
Ascendis Pharma A/S
 126,005 $33,608,053
2 CYTK
Cytokinetics Inc
 239,728 $20,422,428
3 BMRN
Biomarin Pharmaceutical Inc
 288,233 $16,492,692
4 IDYA
IDEAYA Biosciences, Inc.
 386,183 $14,393,040
5 REGN
Regeneron Pharmaceuticals, Inc.
 22,596 $14,089,509
6 RARE
Ultragenyx Pharmaceutical Inc.
 334,854 $11,180,775
7 TYRA
Tyra Biosciences, Inc.
 347,898 $11,111,862
8 BCAX
Bicara Therapeutics Inc.
 353,226 $10,487,279

All Filings in MGNX

Export CSV
16 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $1,885,653 408,150
2026-06-30 $11,088 2,400
2026-03-31 $968,915 335,265
2026-03-31 $219,062 75,800
2026-03-31 $289 100
2025-12-31 $53,419 33,180
2025-09-30 $42,302 25,180
2025-06-30 $30,467 25,180
2024-12-31 $124,647 38,353
2024-09-30 $377,507 114,744
2024-06-30 $866,766 203,945
2024-03-31 $696,476 47,315
2022-12-31 $558,949 83,301
2022-09-30 $487,991 141,038
2022-06-30 $1,705,654 578,188
2022-03-31 $1,885,146 213,978